EW vs. NVNO
EW (Edwards Lifesciences Corporation) and NVNO (enVVeno Medical Corporation) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 5 years, EW returned -5.18%/yr vs -45.26%/yr for NVNO. Their 0.11 correlation means their historical movements had little consistent relationship.
Performance
EW vs. NVNO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EW achieves a 0.96% return, which is significantly higher than NVNO's -5.59% return.
EW
- 1D
- -0.98%
- 1M
- -8.80%
- 6M
- 5.79%
- YTD
- 0.96%
- 1Y
- 8.50%
- 3Y*
- 1.61%
- 5Y*
- -5.18%
- 10Y*
- 8.56%
- ALL TIME*
- 17.35%
NVNO
- 1D
- -0.25%
- 1M
- -4.59%
- 6M
- -11.15%
- YTD
- -5.59%
- 1Y
- -93.78%
- 3Y*
- -61.19%
- 5Y*
- -45.26%
- 10Y*
- —
- ALL TIME*
- -52.17%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $480.40M | $453.68M | $434.27M | |
| $234.78K | $235.71K | $143.02K |
EW vs. NVNO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
EW Edwards Lifesciences Corporation | 0.96% | 15.16% | -2.91% | 2.20% | -42.41% | 42.00% | 17.32% | 52.31% | 11.44% |
NVNO enVVeno Medical Corporation | -5.59% | -89.38% | -41.25% | 0.78% | -22.61% | -23.82% | -37.09% | -62.71% | -70.50% |
Correlation
The correlation between EW and NVNO is 0.01, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.01 |
Correlation (3Y) Balances recent behavior with more history. | 0.04 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.13 |
Correlation (All Time) Calculated using the full available price history since May 31, 2018 | 0.11 |
The correlation between EW and NVNO shifts across timeframes, from 0.01 (1 year) to 0.13 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
EW:
$49.56B
NVNO:
$174.93K
EW:
$1.88
NVNO:
-$87.31
EW:
4.84
NVNO:
0.34
EW:
$6.30B
NVNO:
$0.00
EW:
$4.92B
NVNO:
-$361.00K
EW:
$1.44B
NVNO:
-$15.56M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EW vs. NVNO — Risk / Return Rank
EW
NVNO
EW vs. NVNO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and enVVeno Medical Corporation (NVNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EW | NVNO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.15 | ||
| Sortino ratioReturn per unit of downside risk | +2.39 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 0.72 | +0.36 |
| Calmar ratioReturn relative to maximum drawdown | 0.65 | -0.98 | +1.63 |
| Martin ratioReturn relative to average drawdown | 1.51 | -1.05 | +2.57 |
Loading charts...
Drawdowns
EW vs. NVNO - Drawdown Comparison
The maximum EW drawdown since its inception was -54.32%, smaller than the maximum NVNO drawdown of -99.81%. Use the drawdown chart below to compare losses from any high point for EW and NVNO.
Loading charts...
Drawdown Indicators
| EW | NVNO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.32% | -99.81% | +45.49% |
Max Drawdown (1Y)Largest decline over 1 year | -13.19% | -95.04% | +81.85% |
Max Drawdown (3Y)Largest decline over 3 years | -37.53% | -96.27% | +58.74% |
Max Drawdown (5Y)Largest decline over 5 years | -54.32% | -97.66% | +43.34% |
Max Drawdown (10Y)Largest decline over 10 years | -54.32% | — | — |
Current DrawdownCurrent decline from peak | -34.14% | -99.77% | +65.63% |
Average DrawdownAverage peak-to-trough decline | -14.57% | -90.11% | +75.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.65% | 88.64% | -82.99% |
Volatility
EW vs. NVNO - Volatility Comparison
The current volatility for Edwards Lifesciences Corporation (EW) is 7.05%, while enVVeno Medical Corporation (NVNO) has a volatility of 13.76%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than NVNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EW | NVNO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.05% | 13.76% | -6.71% |
Volatility (6M)Calculated over the trailing 6-month period | 19.74% | 56.04% | -36.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.34% | 116.84% | -92.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.70% | 81.71% | -49.01% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.23% | 93.20% | -60.97% |
Dividends
EW vs. NVNO - Dividend Comparison
Neither EW nor NVNO has paid dividends to shareholders.
Financials
EW vs. NVNO - Financials Comparison
This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and enVVeno Medical Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
EW and NVNO have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVNO has higher volatility (13.76%) compared to EW (7.05%). In terms of maximum drawdown, EW dropped -54.32% vs NVNO's -99.81%.
EW currently has the higher Sharpe Ratio (0.35 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EW and NVNO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer